GM2 activator deficiency
آخر تحديث 2 Apr 2024
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
GM2 activator deficiency (sometimes called GM2 gangliosidosis, AB variant) is a rare inherited disorder that causes progressive brain injury.
اختيارات الفيديو لـ الحالات الوراثيةمكتبة الفيديو
الوصف
GM2 activator deficiency (sometimes called GM2 gangliosidosis, AB variant) is a rare inherited disorder that causes progressive brain injury.
Most individuals with GM2 activator deficiency have the acute infantile form of the disease. Signs and symptoms of acute infantile GM2 activator deficiency typically appear between the ages of 4 and 12 months, when development slows and the muscles used for movement weaken. Infants with acute infantile GM2 activator deficiency stop achieving normal developmental milestones and eventually lose previously acquired skills such as turning over, sitting, and crawling. These infants also develop an exaggerated startle reaction to loud noises. Over time, infants with acute infantile GM2 activator deficiency typically experience seizures, vision loss, and intellectual disabilites. They eventually become unable to respond to their environment. An eye abnormality called a cherry-red spot, which can be identified with an eye examination, is characteristic of the infantile form of this disorder. Infants with acute infantile GM2 activator deficiency may survive into early childhood.
Some people with GM2 activator deficiency may develop milder and more variable signs and symptoms later in life. Due to the rarity of this condition, the full spectrum of the late-onset presentation has not been clearly defined.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
GM2 gangliosidosis, AB variant
Hexosaminidase activator deficiency
Tay-Sachs disease, AB variant
Related patient information and medicines

Patient information leaflet
هل يمكنني تناول المغنيسيوم وفيتامين سي معًا؟
There is no harmful interaction between magnesium and vitamin C. In fact, taking them together is generally considered safe and may even be slightly... Additionally, chronic alcohol use can lead to magnesium deficiency. Always consult your GP, pharmacist, or another qualified healthcare الدعم المهني قبل making decisions about your medications..

Patient information leaflet
هل يمكنني تناول إيزوميبرازول وإنداباميد معًا؟
Why this happens Indapamide is a 'water pill' (diuretic) that helps your body get rid of excess salt and water, but it also causes you to lose potassium and magnesium thro... Esomeprazole هو a proton pump inhibitor (PPI) that can reduce the amount of magnesium your body absorbs from food. When used together, these effects can add up, leading to a.

Patient information leaflet
هل يمكنني تناول حمض الفوليك والمغنيسيوم معًا؟
There is no known harmful interaction between folic acid and magnesium. In fact, t... Important precautions نقص فيتامين B12 (Pernicious Anaemia) حمض الفوليك can mask the symptoms of vitamin B12 deficiency. لدينا Medicines Interaction Checker helps تعتقد check whether your prescriptions, over-the-counter medicines, and supplements are safe to.

Patient information leaflet
ضخامة الكريات وفقر الدم الضخم الأرومات
Macrocytosis refers to red blood cells which are larger than normal. It does not cause any symptoms in itself. Macrocytosis symptoms You may also find relevant information in our other separate leaflet called What is blood. What is blood. Macrocytosis can exist without anaemia. Macrocytosis itself does not cause any symptoms but can be a sign of.

Patient information leaflet
هل يمكنني تناول إيزوميبرازول وفيتامين ب12 معًا؟
Taking esomeprazole for a long time يمكن أن make it harder for your body to absorb vitamin B12 from your food. Over several years, this could lead to a vitamin B12 deficiency. Why this happens Vitamin B12 needs stomach acid to be released from the proteins in your food so it can be absorbed. Esomeprazole works by reducing the amount of acid your.

Patient information leaflet
هل يمكنني تناول فيتامين B2 وفيتامين C معًا؟
Combining alcohol with any medicine also increases the risk of liver ... Using other medicines Taking multiple medicines. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do.
قراءة إضافية ومراجع
- GM2 activator deficiency; MedlinePlus, National Library of Medicine.
- Chen B, Rigat B, Curry C, Mahuran DJ. Structure of the GM2A gene: identification of an exon 2 nonsense mutation and a naturally occurring transcript with an in-frame deletion of exon 2. Am J Hum Genet. 1999 Jul;65(1):77-87. doi: 10.1086/302463.
- Ganne B, Dauriat B, Richard L, Lamari F, Ghorab K, Magy L, Benkirane M, Perani A, Marquet V, Calvas P, Yardin C, Bourthoumieu S. GM2 gangliosidosis AB variant: first case of late onset and review of the literature. Neurol Sci. 2022 Nov;43(11):6517-6527. doi: 10.1007/s10072-022-06270-x. Epub 2022 Aug 4.
- Mahuran DJ. Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim Biophys Acta. 1999 Oct 8;1455(2-3):105-38. doi: 10.1016/s0925-4439(99)00074-5.
- Martins C, Brunel-Guitton C, Lortie A, Gauvin F, Morales CR, Mitchell GA, Pshezhetsky AV. Atypical juvenile presentation of GM2 gangliosidosis AB in a patient compound-heterozygote for c.259G > T and c.164C > T mutations in the GM2A gene. Mol Genet Metab Rep. 2017 Apr 7;11:24-29. doi: 10.1016/j.ymgmr.2017.01.017. eCollection 2017 Jun.
- Sakuraba H, Itoh K, Shimmoto M, Utsumi K, Kase R, Hashimoto Y, Ozawa T, Ohwada Y, Imataka G, Eguchi M, Furukawa T, Schepers U, Sandhoff K. GM2 gangliosidosis AB variant: clinical and biochemical studies of a Japanese patient. Neurology. 1999 Jan 15;52(2):372-7. doi: 10.1212/wnl.52.2.372.
- Salih MA, Seidahmed MZ, El Khashab HY, Hamad MH, Bosley TM, Burn S, Myers A, Landsverk ML, Crotwell PL, Bilguvar K, Mane S, Kruer MC. Mutation in GM2A Leads to a Progressive Chorea-dementia Syndrome. Tremor Other Hyperkinet Mov (N Y). 2015 Jul 9;5:306. doi: 10.7916/D8D21WQ0. eCollection 2015.
- Schepers U, Glombitza G, Lemm T, Hoffmann A, Chabas A, Ozand P, Sandhoff K. Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant. Am J Hum Genet. 1996 Nov;59(5):1048-56.
- Xiao C, Toro C, Tifft C. GM2 Activator Deficiency. 2022 Aug 25. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK583219/
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
2 Apr 2024 | أحدث إصدار
1 Mar 2024 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

